Menu

Neuron Signaling Persists, Faintly, Even When Key Presynaptic Proteins Are Absent

Results from experiments in mice revise a long-held hypothesis that certain protein scaffolds are needed for synaptic activity.

Nov 1, 2016
Ben Andrew Henry

DOCKED: Vesicles continue to release neurotransmitters into the synapse even after researchers disable docking scaffolds.© ISTOCK.COM/COSMIN4000

EDITOR'S CHOICE IN NEUROSCIENCE

The paper
S.S.H. Wang et al., “Fusion competent synaptic vesicles persist upon active zone disruption and loss of vesicle docking,” Neuron, 91:777-91, 2016.

Hair trigger
Neurons send each other signals by firing neurotransmitters across synapses. A stash of neurotransmitter-packed vesicles hunkers close to the presynaptic membrane so the vesicles can fuse with the membrane and release their cargo as soon as an electrical impulse pulls the trigger. An elaborate scaffold of proteins coordinates this vesicle docking, and scientists long assumed these proteins were essential to neuron signaling. For years, Harvard Medical School neuroscientist Pascal Kaeser has wanted “to test that very fundamental hypothesis” by “entirely [removing] that structure.”

Still talking
Kaeser and his colleagues recently got their chance. By genetically altering mice to disable key scaffolding proteins, they prevented vesicles from docking at the presynaptic membrane in cultured neurons. The results “blew us away,” Kaeser says. He expected a total shutdown of neuron signaling, yet vesicles continued to fuse with the presynaptic membrane, though much more slowly.

A simpler time
By stripping out scaffold proteins, the Harvard team might just have turned back the evolutionary clock, says Reinhard Jahn of the Max Planck Institute for Biophysical Chemistry in Germany. Neurons evolved those proteins as improvements to accelerate regular pathways for vesicle secretion, says Jahn. “Maybe we reduced a synapse to one of these more simple pathways of secretion, and that pathway still works,” Kaeser observes.

Reassembly
Defective docking sites are implicated in a range of neurological disorders, from autism to schizophrenia, Kaeser says. “If we could disrupt the entire thing, maybe we could start understanding . . . how it is put together.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.